LAS VEGAS, NV, Jan. 16, 2018 (GLOBE NEWSWIRE) — – Grey Cloak Tech Inc., (OTCQB: GRCK) today announced a strategic partnership with Canbiola, Inc. (OTC: CANB) to list their products on the CBD.co marketplace.
“We’re pleased to be doing a Joint Venture with CBD.co, for the simple reason CBD.Co does the rigorous vetting of all of the products that reside on their site, that’s a creating incredible Marketplace for CBD vendors that qualify,” said Marco Alfonsi, CEO of Canbiola Inc. (CANB) in a recent interview with Grey Cloak Tech CEO Patrick Stiles.
“It’s important to have our two companies work together to create a marketplace that’s amenable to everybody’s thought process moving forward because at the end of the day it’s all about sales. If you can’t sell a product and can’t get the word out there, you get stifled,” said Marco Alfonsi.
To kick off the relationship, Grey Cloak’s Chief Executive Officer, Patrick Stiles, interviewed Canbiola’s CEO, Marco Alfonsi, and Medical Advisory Board Member, Dr. Robert Kornfield, discussing the partnership and the Canbiola products.
These interviews can be found at cbd.co/canbiola
The video interviews are part of CBD.co’s brand new initiative, CBD TV, to create video content around CBD and educate consumers on the different brands and products. CBD TV includes interviews, product reviews and education related to hemp and CBD.
Canbiola announced in the last quarter of 2017 they established a manufacturing agreement with a 3rd party manufacturer in the U.S. whereby Canbiola will be able to directly manufacture at manufacturers cost and white-label others’ products with no upfront fees due from Canbiola. This step makes Canbiola self-sufficient so that we no longer must rely on outside manufacturers, while greatly improving our operating margins from the reduced costs associated with the new agreement. Having this Strategic Alliance with the manufacturing process allows them to leverages state of the art nanotechnology using ultrasonic sound waves to break down the CBD molecule to the size of 30-60 nanometers. This technology leads to high bioavailability of the active ingredients.
Canbiola also has 5 medical advisors on staff including Dr. John P. Salerno,
Patrick Fratellone M.D. RH (AHG) FIM, Smita Ohri M.D., Dr. Harry Benisatto who advise on research and product development.
“We feel 2018 will be exciting for our two companies working together. Moving forward, I think we can tackle the market together,” said Mr. Alfonsi.
CBD.co also started taking Bitcoin and Litecoin cryptocurrencies last week. Opening up the different payments that its customers can use on the site.
Patrick Stiles, Grey Cloak’s Chief Executive Officer said, “Canbiola is the exact type of brand we want on the CBD.co marketplace. They are a premier brand with unique proprietary technology. I’m sure our customers will love their products.”
About Grey Cloak Tech, Inc.
The Company now has two distinct business lines. The Company is still engaged in the sale of cloud-based software to detect advertising fraud on the internet, and through the acquisition of its wholly-owned subsidiary, Eqova Life Sciences, the Company entered the business of distributing a full spectrum of hemp oil products.
Forward-Looking Statements and Safe Harbor Notice
All statements other than statements of historical facts included in this press release are “forward-looking statements” (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as “projected,” “expect,” “possibility,” and “anticipate.” The achievement or success of the matters covered by such forward-looking statements involves significant risks, uncertainties, and assumptions. Actual results could differ materially from current project
ns or implied results. Investors should read the risk factors set forth in the Company’s Annual Report on Form 10-K filed with the SEC on April 17, 2017 and future periodic reports filed with the SEC. All of the Company’s forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.
The Company cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release.